Syndax Pharmaceuticals, Inc. (SNDX)
20.88
+0.51
(+2.50%)
USD |
NASDAQ |
Dec 15, 16:00
20.76
-0.12
(-0.57%)
After-Hours: 07:48
Syndax Pharmaceuticals Research and Development Expense (Annual): 241.64M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Arcutis Biotherapeutics, Inc. | 76.42M |
| ACADIA Pharmaceuticals, Inc. | 303.25M |
| Verastem, Inc. | 81.33M |
| Puma Biotechnology, Inc. | 54.94M |
| Krystal Biotech, Inc. | 53.57M |